Self -control tests can be a solution to increase access to screening in the field of cervical cancer

According to the first study, from scientists from scientists from scientists from scientists from scientists from scientists from scientists from the University of Anderson Center Anderson Center at the center of cervical cancer, cervical cancer, more than twice a double study of cervical cancer among the tests of cervical cancer over twice twice twice doubled in examination took part in the study American and insufficiently screen women from the University of Texas MD Anderson Center.

In a real, randomized prestis study, published today in 41% of people who received self -control tests and a telephone reminder in screening in the field of cervical cancer, compared to only 17% of people who only received a telephone reminder. Adding the patient’s navigation support for self -control tests and telephone reminder increased participation rates to 47%.

Too many women, especially those who are uninsured, live in rural areas or come from marginalized and underrated communities, are not examined for cervical cancer. These results show that self -control tests can be a solution for increasing access to screening, and reducing the load on cervical cancer in the USA ”

Dr. Jane Montealegre, main author, associate professor of behavioral sciences

In May 2025, the Food and Medicine Agency approved the first screening test at home for cervical cancer, a disease that affects almost 13,000 women a year. While HPV vaccinations and examinations in the office caused significant decreases of cervical cancer indicators, the discrepancy of results continues, especially for women in color and in rural poviats and low income.

From February 2020 and August 2023, Prestis was recorded by almost 2,500 women aged 30-65 from around Houston. Most (94%) came from the population of ethnic/racial smaller, and 56% were covered by a financial assistance program financed by society. Patients received one of three methods of screening intervention: 1) telephone reminder for screening; 2) telephone reminder with a self -control test sent; and 3) telephone reminder with sent self -mutilation test and patient navigation. The results of participation in screening tests were collected after six months.

Scientists also found that over 80% of women in self -control groups returned their sets, providing further evidence to preferences and improving the usefulness of this approach in this patient population.

“As self-control tests become available in the United States, it is important that we collect data to conduct the way they are implemented. We want to make sure that they become available in clinics and health centers, who care about people who often have difficulty with access to healthcare,” Montealegre said. “By removing barriers, we hope that we can improve the collection of screening tests based on evidence and make significant progress in relation to this preventive disease.”

The next steps for scientists will be studying how to integrate HPV self -control tests in various primary care conditions.

Restrictions on this study include the effects of Covid-19 pandemic, unclear reasons for refusing to participate and barriers to sending sets to human homes. In the study, it also did not assess the differences in the types of control visits that patients need if they distinguish a positive HPV result.

This study was supported by subsidies from the National Institutes of Health, including the National Institute for Minority Health and the National Cancer Institute (R01MD30175, P30CA016672, P30CA125123, P30CA138313).